We are live on ! Find out more
ACS

Archford Capital Strategies Portfolio holdings

AUM $987M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$136M
AUM Growth
+$10.2M
Cap. Flow
+$3.77M
Cap. Flow %
2.78%
Top 10 Hldgs %
30.52%
Holding
821
New
42
Increased
153
Reduced
89
Closed
40

Top Sells

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$809K
2
GD icon
General Dynamics
GD
+$734K
3
MCD icon
McDonald's
MCD
+$700K
4
DGX icon
Quest Diagnostics
DGX
+$676K
5
TROW icon
T. Rowe Price
TROW
+$612K

Sector Composition

Rank Sector Weight
1 Industrials 16.97%
2 Technology 7.56%
3 Healthcare 5.69%
4 Consumer Staples 5.02%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWK icon
26
American Water Works
AWK
$26.7B
$1.16M 0.85%
21,757
-38
-0.2% -$1.97K
VDC icon
27
Vanguard Consumer Staples ETF
VDC
$7.91B
$1.16M 0.85%
9,227
+110
+1% +$13.5K
VZ icon
28
Verizon
VZ
$196B
$1.13M 0.83%
24,186
+70
+0.3% +$3.42K
D icon
29
Dominion Energy
D
$59.4B
$1.11M 0.82%
14,503
+5,545
+62% +$401K
MSFT icon
30
Microsoft
MSFT
$3.73T
$1.11M 0.82%
23,961
+4,975
+26% +$234K
CVS icon
31
CVS Health
CVS
$119B
$1.09M 0.8%
11,309
+807
+8% +$71.1K
EMR icon
32
Emerson Electric
EMR
$90.8B
$1.07M 0.78%
17,274
+4,141
+32% +$259K
COST icon
33
Costco
COST
$417B
$1.06M 0.78%
7,512
-145
-2% -$19.7K
PG icon
34
Procter & Gamble
PG
$337B
$1.05M 0.77%
11,562
+2,453
+27% +$216K
AOA icon
35
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
$1.03M 0.76%
22,299
+3,944
+21% +$181K
IBB icon
36
iShares Biotechnology ETF
IBB
$9.84B
$1.03M 0.75%
10,143
+126
+1% +$12.2K
HON icon
37
Honeywell
HON
$74.2B
$1.02M 0.75%
11,408
+978
+9% +$84.1K
JNJ icon
38
Johnson & Johnson
JNJ
$623B
$1.01M 0.74%
9,682
+2,239
+30% +$236K
LLTC
39
DELISTED
Linear Technology Corp
LLTC
$1.01M 0.74%
22,173
+6,697
+43% +$292K
QCOM icon
40
Qualcomm
QCOM
$170B
$982K 0.72%
13,214
+3,687
+39% +$270K
GPC icon
41
Genuine Parts
GPC
$18.8B
$977K 0.72%
9,171
+1,015
+12% +$99.5K
CHRW icon
42
C.H. Robinson
CHRW
$17B
$972K 0.71%
12,974
+2,999
+30% +$214K
CMI icon
43
Cummins
CMI
$87.5B
$972K 0.71%
6,741
+47
+0.7% +$6.65K
USB icon
44
US Bancorp
USB
$100B
$964K 0.71%
21,454
PAYX icon
45
Paychex
PAYX
$43.2B
$962K 0.71%
20,841
+3,991
+24% +$184K
NOC icon
46
Northrop Grumman
NOC
$81.8B
$959K 0.71%
6,509
+1,027
+19% +$141K
TMO icon
47
Thermo Fisher Scientific
TMO
$222B
$956K 0.7%
7,633
+13
+0.2% +$1.58K
RTN
48
DELISTED
Raytheon Company
RTN
$940K 0.69%
8,688
+1,284
+17% +$133K
MDLZ icon
49
Mondelez International
MDLZ
$78.5B
$912K 0.67%
25,120
+133
+0.5% +$4.84K
NSC icon
50
Norfolk Southern
NSC
$75.2B
$907K 0.67%
8,272
+1,465
+22% +$161K

Similar funds

Archford Capital Strategies's Q4 2014 Portfolio in Review

As of Q4 2014, Archford Capital Strategies held 821 positions worth $136M, up 8.1% from $126M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Archford Capital Strategies's Q4 2014 filing shows 42 new, 153 increased, 89 reduced and 40 closed positions. Its largest new stake was AstraZeneca: 3,994 shares worth $281K. The largest sale was CSX Corp, an estimated $809K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Archford Capital Strategies's largest Q4 2014 buy was AstraZeneca: 3,994 shares worth $281K.
  • Archford Capital Strategies added most to Dover in Q4 2014, an estimated $857K increase.
  • Archford Capital Strategies's biggest Q4 2014 reduction was CSX Corp, cutting an estimated $809K.
  • Archford Capital Strategies fully exited General Dynamics in Q4 2014, selling an estimated $734K.
  • Archford Capital Strategies's ten largest holdings make up 31% of its $136M portfolio in Q4 2014.
  • Archford Capital Strategies opened 42 new positions and closed 40 in Q4 2014.
  • Archford Capital Strategies's portfolio value rose 8.1% quarter-over-quarter to $136M.

Based on Archford Capital Strategies's 13F filing for Q4 2014, filed 3 Feb 2015.